09:00: WELCOME MESSAGE

09:10: EDUCATIONAL SESSION: State of the Art: Clinical Diagnosis/Workup/Imaging
Clinical Diagnosis/Workup of prevascular mediastinal tumors
Imaging workup of prevascular mediastinal tumors
Q&A

09:40: SCIENTIFIC SESSION: Neoadjuvant Therapy
Neoadjuvant systemic therapy
Radiological response to neoadjuvant therapy
Effects of neoadjuvant therapy on surgery
Pathologic responses to neoadjuvant therapy
Q&A 

10:40: BREAK

11:00: ITMIG Society/Committee Update
Committee reports/introduction
Committee highlights: Membership
Committee highlights: Thymic Carcinoma and Mediastinal Working Groups
Committee highlights: Education
Committee highlights: Retrospective/Prospective Database
Committee highlights: Communication
Projects that need a leader
Q&A

12:20: LUNCH BREAK/POSTER SESSION 1

13:00: EDUCATIONAL SESSION: Neurology and autoimmune phenomena
Clinical Neurology
Perioperative anesthesia management of MG and patients with large mediastinal tumors
Patient Perspective
Q&A

13:40: SCIENTIFIC SESSION: Immunotherapy and Onco-Immunology
Immunotherapy: Common toxicities and update on clinical trials
Adoptive Cell Therapies and cytokine release syndrome
Management of immunosuppressed patients and immunological disorders beyond MG
Uncommon manifestations of paraneoplastic autoimmunity
Q&A 

14:40: BREAK

15:00 EDUCATIONAL SESSION: State of the Art: Pathology
Histology of thymic tumors
Single-cell transcriptomics of thymic epithelial tumorigenesis
Molecular pathology/Genetics of thymic tumors
Q&A

15:40: SCIENTIFIC SESSION: Pleural disease
Management of pleural disease
Complex surgeries for pleural disease
Systemic treatment for recurrent/metastatic thymoma
Radiation treatments for pleural disease
Patient Perspective
Q&A 

16:50: BREAK

17:10: ORAL ABSTRACT SESSION 1

18:00: CLOSING OF THE  SCIENTIFIC PART

09:00: EDUCATIONAL SESSION: State of the Art: Surgical Management of Thymic Tumors: include pleural disease
Q&A

09:30: SCIENTIFIC SESSION: Other mediastinal tumors
Surgical management of germ cell tumors
Surgical management of posterior mediastinal/neurogenic tumors
Radiology
Germ cell tumor pathology
Pathology of other mediastinal tumors
Q&A 

10:40: BREAK

11:00: SCIENTIFIC SESSION: Myasthenia gravis and biomarkers
Cutting edge developments and new therapeutics for Myasthenia Gravis
Pathogenesis of Thymoma-Associated Maysthenia Gravis
Cancer and Autoimmunity: Survivin as a driver of sustaining autoreactive cells and its role in neoplasia
Biomarker development for Myasthenia Gravis
Q&A 

12:00: ITMIG 2023 Picture

12:10: LUNCH BREAK/POSTER SESSION 2

13:00: EDUCATIONAL SESSION: State of the Art: Medical Oncology
Q&A

13:30: EDUCATIONAL SESSION: TNM Update
Q&A

14:00: BREAK

14:20: EDUCATIONAL SESSION: State of the Art: Radiation Oncology
Q&A

14:50: SCIENTIFIC SESSION: The future of Thymic Tumor Management
Thymic Oncology in 2043: Surgery
Thymic Oncology in 2043: Systemic therapy
Thymic Oncology in 2043: Radiation Oncology
Thymic Oncology in 2043: Radiology
Thymic Oncology in 2043: Pathology
Q&A  

16:00: BREAK

16:20: SCIENTIFIC SESSION: TUMOR BOARD

17:10: ORAL ABSTRACT SESSION 2

18:00: Final Announcements and Conference Conclusion

18:10: CLOSING OF THE SCIENTIFIC PART